Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences, Inc. - Special Call Transcript

Sep 02, 2020 / 08:30PM GMT
Release Date Price: $45.82 (-0.61%)
Operator

Good afternoon, and welcome to Castle Biosciences DecisionDx-SCC Launch Conference Call. As a reminder, today's call is being recorded. We will begin today's call with opening remarks and introductions, followed by a question-and-answer session.

I would like to turn the call over to Frank Stokes, Chief Financial Officer. Please go ahead.

Frank Stokes
Castle Biosciences, Inc. - CFO

Thank you, operator. Good afternoon, everyone. Welcome to Castle Biosciences DecisionDx-SCC Launch Conference Call. As with most presentations, the following discussion contains forward-looking statements, and our actual results may differ materially from those discussed here. Additional information concerning factors that could cause such a difference can be found in the disclaimer slide included in the presentation and the company's quarterly report on Form 10-Q for the quarter ended June 30, 2020, and the annual report on Form 10-K for the year ended December 31, 2019.

I'll now direct you to our agenda today. We appreciate your interest, and we will go through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot